Predicting protein-ligand binding sites based on an improved geometric algorithm

Protein and Peptide Letters

Volumn 18, Issue 10, 2011, Pages 997-1001

  He, Jing ^a   Wei, Dong Qing ^a,e   Wang, Jing Fang ^b,c,e   Chou, Kuo Chen ^d  

^a Shanghai Jiao Tong University   (China)

^b Shanghai Jiao Tong University   (China)

^c SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^d GORDON LIFE SCIENCE INSTITUTE   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Binding site prediction; Geometrybased approach; Molecular docking; Protein ligand interactions; Structure based drug design

Indexed keywords

ALGORITHM; ARTICLE; BINDING SITE; COMPUTER PREDICTION; GEOMETRY; MOLECULAR DOCKING; PROTEIN DATABASE; PROTEIN INTERACTION; PROTEIN LIGAND BINDING SITE; PROTEIN STRUCTURE;

ALGORITHMS; BINDING SITES; COMPUTATIONAL BIOLOGY; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960582885     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611796378756     Document Type: Article

References (61)

1. Chou, K.C. Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.
2. Chen, Y.; Han, K. BSFINDER: Finding Binding Sites of HCV Proteins Using a Support Vector Machine. Protein Pept. Lett., 2009, 16, 373-382.
3. Ivanciuc, O.; Braun, W. Robust quantitative modeling of peptide binding affinities for MHC molecules using physical-chemical descriptors. Protein Pept. Lett., 2007, 14, 903-916. (Pubitemid 350013828)
4. Kuntal, B.K.; Aparoy, P.; Reddanna, P. Development of tools and database for analysis of metal binding sites in protein. Protein Pept. Lett., 2010, 17, 765-773.
5. Chou, K.C.; Wei, D.Q.; Du, Q.S.; Sirois, S.; Zhong, W.Z. Progress in computational approach to drug development against SARS. Curr. Med. Chem., 2006, 13, 3263-3270. (Pubitemid 44669774)
6. Qiu, Z.; Wang, X. Identification of ligand-binding pockets in proteins using residue preference methods. Protein Pept. Lett., 2009, 16, 984-990.
7. Tian, F.; Lv, F.; Zhou, P.; Yang, Q.; Jalbout, A.F. Toward prediction of binding affinities between the MHC protein and its peptide ligands using quantitative structure-activity relationship approach. Protein Pept. Lett., 2008, 15, 1033-1043.
8. Chou, K.C.; Wei, D.Q.; Du, Q.S.; Sirois, S.; Shen, H.B.; Zhong, W.Z. In Proteases in Biology and Disease: Viral proteases and antiviral protease inhibitor therapy; Lendeckel, U., Hooper, N. M., Eds.; Springer Science: Media B.V., 2009; Vol. 8.
9. Wang, J.F.; Wei, D.Q.; Chen, C.; Li, Y.; Chou, K.C. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein Pept. Lett., 2008, 15, 27-32. (Pubitemid 351206472)
10. Wang, J.F.; Chou, K.C. Insights from modeling the 3D structure of New Delhi metallo-beta-lactamase and its binding interactions with antibiotic drugs. PLoS ONE 2011, 6, e18414.
11. Schnell, J.R.; Chou, J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 2008, 451, 591-595. (Pubitemid 351186272)
12. Pielak, R. M.; Jason R. Schnell, J. R.; Chou, J. J. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci USA, 2009, 106, 7379-7384.
13. Wang, J.F.; Wei, D.Q.; Chou, K.C. Drug candidates from traditional chinese medicines. Curr. Top. Med. Chem., 2008, 8, 1656-1665.
14. Wang, J.F.; Yan, J.Y.; Wei, D.Q.; Chou, K.C. Binding of CYP2C9 with diverse drugs and its implications for metabolic mechanism. Med. Chem., 2009, 5, 263-270.
15. Chou, K.C.; Wei, D.Q.; Zhong, W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
16. Lian, P.; Wei, D.Q.; Wang, J.F.; Chou, K.C. An allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranes. PLoS ONE, 2011, 6, e18587.
17. Wang, J.F.; Chou, K.C. Insights from studying the mutationinduced allostery in the M2 proton channel by molecular dnamics. Protein Eng. Des. Sel., 2010, 23, 663-666.
18. Wang, J.F.; Chou, K.C. Molecular modeling of cytochrome P450 and drug metabolism. Curr. Drug. Metab., 2010, 11, 342-346.
19. Wang, Y.; Wei, D.Q.; Wang, J.F. Molecular dynamics studies on T1 lipase: Insight into a double-flap mechanism. J. Chem. Inf. Model., 2010, 50, 875-878.
20. Gu, H.; Chen, H.F.; Wei, D.Q.; Wang, J.F.. Molecular dynamics simulations exploring drug resistance in HIV-1 proteases. Chiese Sci. Bull., 2010, 55, 2677-2683.
21. Wang, J.F.; Chou, K.C. Insight into the molecular switch mechansm of human Rab5a from molecular dynamics simulations. Biochem. Biophys. Res. Commun., 2009, 390, 608-612.
22. Wang, J.F.; Wei, D.Q.; Chou, K.C. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem. Biophys. Res. Commun., 2009, 388, 413-417.
23. Wang, J.F.; Gong, K.; Wei, D.Q.; Li, Y.X.; Chou, K.C. Molecular dynamics studies on the interactions of PTP1B with inhibitors: From the first phosphate-binding site to the second one. Protein. Eng. Des. Sel., 2009, 22, 349-355.
24. Wang, J.F.; Gong, K.; Wei, D.Q.; Li, Y.X. Structural flexibility and interactions of PTP1B's S-loop. Interdiscip. Sci., 2009, 1, 214-219.
25. Wang, J.F.; Wei, D.Q.; Li, L.; Zheng, S.Y.; Li, Y.X.; Chou, K.C. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem. Biophys. Res. Commun., 2007, 355, 513-519. (Pubitemid 46282658)
26. Wang, J.F.; Wei, D.Q.; Lin, Y.; Wang, Y.H.; Du, H.L.; Li, Y.X.; Chou, K.C. Insights from modeling the 3D structure of NAD(P)Hdependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP. Biochem. Biophys. Res. Commun., 2007, 359, 323-329. (Pubitemid 46887686)
27. Gong, K.; Li, L.; Wang, J.F.; Cheng, F.; Wei, D.Q.; Chou, K.C. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design. Med. Chem., 2009, 5, 242-249.
28. Gu, R.X.; Gu, H.; Xie, Z.Y.; Wang, J.F.; Arias, H.R.; Wei, D.Q.; Chou, K.C. Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. Med. Chem., 2009, 5, 250-262.
29. Wang, J.F.; Zhang, C.C.; Wei, D.Q. Docking and molecular dynamics studies on CYP2D6. Chinese Sci. Bull., 2010, 55, 1877- 1880.
30. Wang, J.F.; Wei, D.Q.. Role of structural bioinformatics and traditional Chinese medicine databases in pharmacogenomics. Pharmacogenomics, 2009, 10, 1213-1215.
31. Wang, J.F.; Zhang, C.C.; Chou, K.C.; Wei, D.Q. Structure of cytochrome P450s and personalized drug. Curr. Med. Chem., 2009, 16, 232-244.
32. Wang, J.F.; Wei, D.Q.; Chou, K.C. Pharmacogenomics and personalized use of drugs. Curr. Top. Med. Chem., 2008, 8, 1573-1579.
33. Ghalanbor, Z.; Ghaemi, N.; Marashi, S.A.; Amanlou, M.; Habibi- Rezaei, M.; Khajeh, K.; Ranjbar, B. Binding of Tris to Bacillus licheniformis alpha-amylase can affect its starch hydrolysis activity. Protein Pept. Lett., 2008, 15, 212-214. (Pubitemid 351346475)
34. Gupta, A.; Gandhimathi, A.; Sharma, P.; Jayaram, B. ParDOCK: An all atom energy based Monte Carlo docking protocol for proteinligand complexes. Protein Pept. Lett., 2007, 14, 632-646. (Pubitemid 47416367)
35. Nose, T.; Shimohigashi, Y. A docking modelling rationally predicts strong binding of bisphenol A to estrogen-related receptor gamma. Protein Pept. Lett., 2008, 15, 290-296. (Pubitemid 351457379)
36. Rizzi, L.; Vaiana, N.; Sagui, F.; Genesio, E.; Pilli, E.; Porcari, V.; Romeo, S. Design, synthesis and docking studies of Hydroxyethylamine and Hydroxyethylsulfide BACE-1 inhibitors. Protein Pept. Lett., 2009, 16, 86-90.
37. Singh, V.; Somvanshi, P. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis. Protein Pept. Lett., 2010, 17, 269-276.
38. Smith, D. L.; Nilar, S.H. Homology modeling studies of yeast Mitogen-Activated Protein Kinases (MAPKS): Structural motifs as a basis for specificity. Protein Pept. Lett., 2010, 17, 732-738.
39. Zahed, M.; Suzuki, T.; Suganami, A.; Sugiyama, H.; Harada, K.; Takiguchi, M.; Tamura, Y.; Suzuki, N. Screening of SMG7- binding peptides by combination of phage display and docking simulation analysis. Protein Pept. Lett., 2009, 16, 301-305.
40. Chou, K.C.; Jones, D.; Heinrikson, R.L. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett., 1997, 419, 49-54. (Pubitemid 28011215)
41. Du, Q.S.; Huang, R.B.; Wang, C.H.; Li, X.M.; Chou, K.C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol., 2009, 259, 159-164.
42. Cai, Y.D.; Zhou, G.P.; Jen, C.H.; Lin, S.L.; Chou, K.C. Identify catalytic triads of serine hydrolases by support vector machines. J. Theor. Biol., 2004, 228, 551-557.
43. Chou, K.C.; Cai, Y.D. A novel approach to predict active sites of enzyme molecules. Proteins., 2004, 55, 77-82.
44. Du, Q.S.; Huang, R.B.; Wang, S.Q.; Chou, K.C. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus. PLoS ONE, 2010, 5, e9388.
45. Wang, S.Q.; Cheng, X.C.; Dong, W.L.; Wang, R.L.; Chou, K.C. Three new powerful Oseltamivir derivatives for inhibiting the neuraminidase of influenza virus. Biochem. Biophys. Res. Commun., 2010, 401, 188-191.
46. Chou, K.C.; Zhou, G.P. Role of the protein outside active site on the diffusion-controlled reaction of enzyme. J. Am. Chem. Soc., 1982, 104, 1409-1413.
47. Arkin, M.R.; Wells, J.A. Small-molecule inhibitors of proteinprotein interactions: Progressing towards the dream. Nat. Rev. Drug. Discov., 2004, 3, 301-317. (Pubitemid 38499758)
48. Liang, J.; Edelsbrunner, H.; Woodward, C. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Sci., 1998, 7, 1884-1897. (Pubitemid 28432430)
49. Peters, K. P.; Fauck, J.; Frommel, C. The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. J. Mol. Biol., 1996, 256, 201-213. (Pubitemid 26104219)
50. Laurie, A.T.; Jackson, R.M. Methods for the prediction of proteinligand binding sites for structure-based drug design and virtual ligand screening. Curr. Protein Pept. Sci., 2006, 7, 395-406. (Pubitemid 44524489)
51. Levitt, D.G.; Banaszak, L.J. POCKET: A computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. J. Mol. Graph., 1992, 10, 229-234. (Pubitemid 23018967)
52. Hendlich, M.; Rippmann, F.; Barnickel, G. LIGSITE: Automatic and efficient detection of potential small molecule-binding sites in proteins. J. Mol. Graph. Model., 1997, 15, 359-363, 389. (Pubitemid 28409807)
53. Brady, G.P., Jr.; Stouten, P.F. Fast prediction and visualization of protein binding pockets with PASS. J. Comput. Aided Mol. Des., 2000, 14, 383-401. (Pubitemid 30219399)
54. Binkowski, T.A.; Naghibzadeh, S.; Liang, J. CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Res., 2003, 31, 3352-3355. (Pubitemid 37442157)
55. Laurie, A.T.; Jackson, R.M. Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites. Bioinformatics, 2005, 21, 1908-1916. (Pubitemid 40668026)
56. Goodford, P.J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem., 1985, 28, 849-857. (Pubitemid 15012490)
57. Efron, B. The convex hull of a random set of points. Biometrika, 1965, 52, 331-343.
58. Hueter, I. Limit theorems for the convex hull of random points in higher dimensions. T. Am. Math. Soc., 1999, 351, 4337-4363.
59. Ahmad, S.; Gromiha, M.; Fawareh, H.; Sarai, A. ASAView: Database and tool for solvent accessibility representation in proteins. BMC Bioinformatics, 2004, 5, 51.
60. Kabsch, W.; Sander, C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 1983, 22, 2577-2637.
61. Wang, R.; Fang, X.; Lu, Y.; Wang, S. The PDBbind database: Collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J. Med. Chem., 2004, 47, 2977-2980. (Pubitemid 38702694)